Raffles Medical GroupRAFLF 57 Return-on-Tangible-Equity is 7.49% as of Dec. 2025, which is 19% below its 10-year median of 9.20. GuruFocus rates RAFLF with a GF Score™ of 57/100 and a GF Value™ of $0.75 (Fairly Valued). The stock has 4 warning signs investors should review. Among 579 Healthcare Providers & Services companies, Raffles Medical Group ranks worse than 58.2% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Raffles Medical Group's annualized net income for the quarter that ended in Dec. 2025 was $59.6 Mil. Raffles Medical Group's average shareholder tangible equity for the quarter that ended in Dec. 2025 was $796.0 Mil. Therefore, Raffles Medical Group's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2025 was 7.49%.
The historical rank and industry rank for Raffles Medical Group's Return-on-Tangible-Equity or its related term are showing as below:
RAFLF'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 6.09 Med: 9.2 Max: 14.91
Current: 6.87
During the past 13 years, Raffles Medical Group's highest Return-on-Tangible-Equity was 14.91%. The lowest was 6.09%. And the median was 9.20%.
RAFLF's Return-on-Tangible-Equity is ranked worse than 58.2% of 579
companies
in the Healthcare Providers & Services industry
Industry Median: 10.13
vs RAFLF: 6.87
Raffles Medical Group (OTCPK:RAFLF) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Raffles Medical Group Return-on-Tangible-Equity Related Terms
Raffles Medical Group Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Raffles Medical Group's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Raffles Medical Group Return-on-Tangible-Equity Chart
RAFLF vs HCA, THC, DVA: Return-on-Tangible-Equity Comparison
For the Medical Care Facilities subindustry, Raffles Medical Group's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Raffles Medical Group Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Raffles Medical Group's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Raffles Medical Group's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Dec. 2025) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 7.49% mean?
Raffles Medical Group (RAFLF) has a Return-on-Tangible-Equity of 7.49% as of Dec. 2025. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Raffles Medical Group and its competitors. This is 19% below median its historical median of 9.20. Over the past decade, Raffles Medical Group's Return-on-Tangible-Equity has ranged from 6.09 to 14.91. According to the industry distribution chart, Raffles Medical Group ranks #337 out of 579 companies in the Healthcare Providers & Services industry, placing it in the top 58.2%.
Is Raffles Medical Group's Return-on-Tangible-Equity too high?
Raffles Medical Group's current Return-on-Tangible-Equity of 7.49% is 19% below median its 10-year median of 9.20. Over the past 10 years, this metric has ranged from a low of 6.09 to a high of 14.91. The Healthcare Providers & Services industry median Return-on-Tangible-Equity is 10.13. Raffles Medical Group's value of 7.49% is 26.1% below this industry median. Based on the distribution chart, Raffles Medical Group ranks #337 out of 579 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Raffles Medical Group has a GF Score™ of 57/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Raffles Medical Group's Return-on-Tangible-Equity compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Raffles Medical Group ranks #337 out of 579 companies for Return-on-Tangible-Equity. This places Raffles Medical Group in the lower half of its industry. The industry median Return-on-Tangible-Equity is 10.13. Raffles Medical Group's value of 7.49% is 26.1% below this benchmark. Historically, Raffles Medical Group's own Return-on-Tangible-Equity has ranged from 6.09 to 14.91 over the past decade. While the company's 10-year median is 9.20 vs. the industry median of 10.13, Raffles Medical Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.13, based on 579 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Raffles Medical Group's current Return-on-Tangible-Equity of 7.49% is 26.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Raffles Medical Group and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Raffles Medical Group's current Return-on-Tangible-Equity is 7.49%, which is 19% below median its own 10-year median of 9.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Raffles Medical Group stock overvalued right now?
Based on GuruFocus' analysis, Raffles Medical Group (RAFLF) is currently considered Fairly Valued. The stock's GF Value™ is $0.75, compared to a current price of $0.75 — trading 0.4% above its estimated fair value. The current Return-on-Tangible-Equity is 7.49%, which is 19% below median its 10-year median of 9.20 and 26.1% below the Healthcare Providers & Services industry median of 10.13. Raffles Medical Group's overall GF Score™ is 57/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Raffles Medical Group (RAFLF), the current Return-on-Tangible-Equity is 7.49% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Raffles Medical Group (RAFLF) Overvalued in 2026?
Based on GuruFocus' analysis, Raffles Medical Group stock appears to be overvalued.
The current stock price of $0.75 is trading 0.4% above its estimated GF Value™ of $0.75.
GuruFocus considers Raffles Medical Group to be Fairly Valued.
Key valuation signals for RAFLF:
Return-on-Tangible-Equity: 7.49% (19% below median its 10-year median of 9.20)
GF Value™: $0.75 vs. price of $0.75 (0.4% above fair value)
Industry Position: 26.1% below the Healthcare Providers & Services median (#337 of 579)
No single metric tells the full story. See the RAFLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Raffles Medical Group Ltd is an integrated private healthcare provider in Asia with operations in Singapore, China, Japan, Vietnam, and Cambodia. The company owns and operates a tertiary hospital, a network of medical and dental clinics, insurance services, Japanese and Traditional Chinese Medicine clinics, and a consumer healthcare division. The company's operating segment includes Healthcare services, Hospital Services, Investment Holdings, and Insurance Services. The company generates revenue from contracts with customers, Rental Income, and Insurance revenue. Geographically operates in Singapore, Greater China, Vietnam, Cambodia and Japan.
57GF Score
Get the complete analysis for RAFLF
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RAFLF has been successfully added to your 
